Multiple studies have demonstrated disappointingly low rates of persistence with therapies recommended to reduce cardiovascular risk. Non face-to-face communication has been employed as a strategy to increase the rate of adherence with both pharmacologic and lifestyle modification risk-reduction measures. In addition to the impact on adherence, these interventions have the potential to affect intermediate measures, such as increased access to care, increased patient satisfaction, and decreased resource utilization. Improvement in clinical outcomes is the ultimate measure of success of this intervention.
From the Akron General Medical Center, Akron, Ohio.
Corresponding author: Suzanne Hughes, RN, MSN, Akron General Health & Wellness Center, Suite 205, 4125 Medina Rd, Akron, OH 44333 (e-mail: firstname.lastname@example.org).